JP-1302 (hydrochloride hydrate)
CAY-25974-5 5 mg
Data Sheet: 
SDS:
SDS:
Formulation
A solid
Purity
≥98%
MW
441,4
Shipment
-20
Long Term Storage
-20
Shelf Life
1460
Description
An α2C-AR antagonist; selective for α2C-ARs over α2A- and α2B-ARs (Kis = 28, 3,150, and 1,470 nM, respectively); reduces immobility time in the forced swim test in mice at 1, 3, and 10 μmol/kg; reverses phencyclidine-induced decreases in prepulse inhibition of the acoustic startle response in rat at 5 mg/kg; dose-dependently reduces haloperidol-induced bradykinesia and catalepsy in mice; increases systolic blood pressure in rats at 0.3 mg/kg
ESCLUSIVAMENTE PER USO DI RICERCA (RUO) e non per uso terapeutico o diagnostico su uomini o animali. Il prodotto NON è un Dispositivo Medico o un Diagnostico in Vitro.
PRODUCT FOR RESEARCH USE ONLY (RUO) and not for therapeutic or diagnostic use on humans or animals. The product is NOT a Medical Device or an In-Vitro Diagnostic (IVD).
